ALSO READGovt tenders may opt for local medical devices New pharma marketing code targets to cut drug price After stent, NPPA starts process to cap other medical devices No proposal to extend price cap to other medical devices, says NPPA chief Markets continue trading lower in noon trade; pharma stocks drag
The company successfully completed inspection by Pharmaceuticals and Medical Devices Agency (PMDA) Japanese Authorities for the manufacturing facility-Unit II, located in Hyderabad – Telangana.
The inspection was done during the period July 25 – 27. The inspection was focussed on general GMP (Good Manufacturing Practice) inspection of the site. The inspection has been concluded with no critical/major observation.
At 02:52 PM; the stock was up 16% to Rs 84.35 on BSE, as compared to 0.95% rise in the S&P BSE Sensex. The trading volumes on the counter jumped multiple-fold with a combined 1.2 million shares changed hands on BSE and NSE so far.